生物材料在牙髓治疗中的再生潜力与临床应用:系统综述
Scaffold-based and calcium-silicate biomaterials in vital pulp therapy: a systematic review of current evidence and translational perspectives
该系统综述评估了生物材料(如钙硅酸盐材料和再生支架)在牙髓治疗中的生物反应和临床效果,强调了再生支架在实验研究中的潜力与临床应用的局限性。
Introduction
Preservation of the dentine–pulp complex remains a central objective of contemporary endodontic practice. The biological integrity of the pulp is fundamental not only to tooth vitality but also to long-term structural resilience, immunological defence, and proprioceptive function. As a dynamic and highly specialised tissue system, the dentine–pulp complex possesses an intrinsic capacity to respond to injury through coordinated inflammatory and reparative processes aimed at maintaining function [1, 2]. This responsiveness underpins the rationale for increasingly conservative treatment approaches and reflects a broader shift in modern dentistry towards minimally invasive strategies that prioritise tissue preservation.
Encased within rigid dentinal walls, the pulp is a richly vascularised and innervated connective tissue that is particularly susceptible to pressure changes and inflammatory insult. In response to caries, trauma, or operative intervention, it initiates a coordinated cascade involving immune cell recruitment, cytokine signalling, and activation of progenitor cells [1]. These responses are tightly regulated and may culminate in resolution and repair or progress towards irreversible damage, depending on the magnitude and duration of the insult. Importantly, pulpal healing occurs along a continuum rather than as a binary process, influenced by bacterial burden, host immune competence, and the local microenvironment within the pulp chamber.
Within this context, VPT has emerged as a biologically driven treatment modality designed to preserve pulpal vitality in teeth affected by caries or trauma [3, 4]. Historically, pulpal disease was frequently managed through complete extirpation; however, advances in diagnostic understanding and biomaterials have enabled a transition towards more conservative strategies. Contemporary VPT procedures, including direct pulp capping, partial pulpotomy, and full pulpotomy, are supported by a growing body of clinical evidence demonstrating favourable outcomes when appropriate case selection and material selection are applied [5,6,7,8].
A key determinant of success in VPT lies in the ability to modulate inflammation while preserving a viable population of pulp cells capable of initiating repair. Controlled inflammatory responses may stimulate differentiation of odontoblast-like cells and subsequent deposition of tertiary dentine, forming a protective barrier against further insult [1, 2]. In contrast, sustained or excessive inflammation compromises this reparative capacity and may lead to irreversible tissue breakdown. This balance underscores the importance of both biological understanding and material performance in shaping clinical outcomes.
The introduction of calcium-silicate biomaterials, particularly mineral trioxide aggregate and Biodentine, has been instrumental in advancing VPT. These materials combine biocompatibility, bioactivity, and effective sealing ability, creating an environment conducive to pulpal healing and hard tissue formation [9, 10]. Their capacity to release calcium ions and promote mineralised interface formation supports cellular differentiation and reparative dentinogenesis, while their sealing properties limit bacterial ingress and subsequent inflammation.
Clinical investigations have consistently reported high success rates associated with these materials across a range of VPT procedures [4,5,6,7,8]. This reliability has established them as the current standard of care. Nevertheless, the biological response they elicit is predominantly reparative rather than regenerative.
Reparative dentinogenesis results in the formation of a dentine bridge that, although clinically protective, does not fully replicate the structural or functional characteristics of native dentine [11]. The resulting tissue often exhibits irregular tubular organisation, reduced mechanical properties, and limited integration with the existing dentine–pulp complex. From a biological perspective, this represents healing rather than true regeneration. Complete regeneration would require restoration of native architecture, including organised odontoblast layers, vascular networks, and neural components [11,12,13].
These limitations have driven increasing interest in regenerative endodontics, an evolving field focused on restoring functional pulp tissue through biologically driven approaches [12, 14,15,16,17]. Grounded in tissue engineering principles, these strategies aim to harness interactions between scaffolds, signalling molecules, and stem or progenitor cells to promote organised tissue formation and functional recovery.
Among these approaches, regenerative scaffold systems have attracted particular attention. Biomimetic constructs provide a three-dimensional framework that facilitates cellular attachment, proliferation, and differentiation while supporting vascularisation and nutrient diffusion [13, 18]. Advances in biomaterial engineering, including hydrogels and three-dimensional printed matrices, have enabled increasingly sophisticated designs that more closely replicate the native extracellular environment. Beyond their structural role, such systems may also function as delivery platforms for bioactive molecules, including growth factors and signalling peptides, thereby enhancing cellular recruitment and guiding tissue development within the pulp space. This integration of structural and biochemical cues represents a critical step towards achieving functional regeneration rather than mere tissue replacement [19].
Experimental studies have reported promising outcomes, including the formation of vascularised pulp-like tissue, deposition of dentine-like structures, and expression of odontogenic markers [20,21,22,23,24]. These findings suggest that regenerative scaffold approaches may overcome some of the inherent limitations of conventional biomaterials. However, despite these advances, translation into predictable clinical outcomes remains constrained.
Multiple factors contribute to this translational gap. Successful regeneration of the dentine–pulp complex requires precise coordination of vascularisation, cellular signalling, and host–material interactions. The establishment of a functional vascular network is particularly critical, as sustained tissue viability depends on adequate perfusion. In addition, host immune response and the multifactorial nature of the in vivo environment introduce variables that are difficult to replicate under controlled experimental conditions [1, 11, 13, 16].
Consequently, while regenerative scaffold systems reveal considerable potential in experimental settings, their clinical applicability remains uncertain. In contrast, calcium-silicate biomaterials continue to deliver predictable and reproducible outcomes within a reparative framework.
This divergence between experimental promise and clinical reliability underscores a persistent translational gap in the current evidence base. A structured evaluation of the available literature is therefore required to critically examine the current evidence supporting these biomaterial strategies and to identify the translational challenges that continue to limit clinical regeneration.
Accordingly, this systematic review aimed to critically synthesise the current evidence relating to scaffold-based regenerative biomaterials and calcium-silicate biomaterials in VPT. Emphasis was placed on identifying the regenerative potential, clinical performance and methodological limitations of the available evidence, while exploring the translational challenges that currently limit the progression of scaffold-based regenerative strategies from experimental models to routine clinical practice.
Methods
Registration and reporting
This systematic review was conducted according to a predefined methodology established prior to the initiation of the literature search and is reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA 2020) statement [25]. The review protocol was not prospectively registered (e.g. PROSPERO), as the study was undertaken within an academic research framework. Nevertheless, the review question, eligibility criteria, search strategy, and planned methods of synthesis were established a priori and remained unchanged throughout the review. The absence of prospective protocol registration is acknowledged as a methodological limitation and was considered when interpreting the findings.
Focus question and PICO framework
The review sought to answer the following focus question:
“What does the current evidence reveal about scaffold-based regenerative biomaterials and calcium-silicate biomaterials in vital pulp therapy, and what are the implications for their translation into clinical practice?”
The review question was developed using the Population, Intervention, Comparison, and Outcome (PICO) framework to ensure a structured and transparent approach to study selection.
-
Population (P): Teeth undergoing VPT.
-
Intervention (I): Scaffold-based regenerative biomaterials designed to support regeneration of the dentine–pulp complex.
-
Comparison (C): Calcium-silicate biomaterials used in VPT, including mineral trioxide aggregate (MTA) and Biodentine.
-
Outcome (O): Biological, histological, radiographic and clinical outcomes relating to regeneration or preservation of the dentine–pulp complex, including maintenance of pulpal vitality, tissue organisation and dentine formation.
Search strategy
A comprehensive electronic search of the published literature was undertaken in MEDLINE (accessed via PubMed), Scopus and Web of Science from database inception to March 2025 to identify studies evaluating scaffold-based regenerative biomaterials and calcium-silicate biomaterials in VPT.
The electronic search strategy combined controlled vocabulary (Medical Subject Headings [MeSH], where applicable) with free-text keywords relating to VPT, scaffold-based regenerative biomaterials and calcium-silicate biomaterials. Boolean operators (AND/OR) were used to combine search concepts and maximise retrieval of relevant studies while maintaining search specificity.
The core search strategy included the terms “vital pulp therapy”, “pulpotomy”, “direct pulp capping”, “scaffold”, “hydrogel”, “3D printed scaffold”, “tissue engineering”, “calcium silicate”, “mineral trioxide aggregate” and “Biodentine”. The complete electronic search strategy for MEDLINE (via PubMed) is provided in Supplementary Material 1. Equivalent search strategies were adapted for Scopus and Web of Science using database-specific syntax.
Retrieved records were screened according to the predefined eligibility criteria. Only articles published in English were considered for inclusion. Eligible study designs comprised human clinical investigations and in vivo animal studies. In addition to electronic database searching, the reference lists of all included studies and relevant review articles were manually screened to identify any additional eligible publications.
Eligibility criteria
Eligibility criteria were established a priori in accordance with the review question and PICO framework to ensure a transparent, reproducible, and consistent study selection process.
Studies were considered eligible for inclusion if they satisfied all the following predefined eligibility criteria:
Inclusion criteria
-
Population: Teeth undergoing VPT.
-
Intervention: Scaffold-based regenerative biomaterials or calcium-silicate biomaterials used in VPT.
-
Study design: Human clinical studies and in vivo animal investigations.
-
Outcomes: Biological, histological, radiographic and/or clinical outcomes relating to preservation or regeneration of the dentine–pulp complex.
-
Publication characteristics: Full-text articles published in English.
Exclusion criteria
Studies were excluded if they met one or more of the following criteria:
-
were narrative reviews or expert opinion articles.
-
were in vitro studies without in vivo validation.
-
were not related to VPT or pulp regeneration.
-
did not evaluate scaffold-based regenerative biomaterials or calcium-silicate biomaterials.
-
did not report biological or clinical outcomes relevant to preservation or regeneration of the dentine–pulp complex.
Study selection and data extraction
All records identified through the electronic database searches were imported into EndNote, where duplicate records were identified and removed prior to screening.
Titles and abstracts of all retrieved records were screened against the predefined eligibility criteria by one reviewer (M.S.). Studies considered potentially eligible subsequently underwent full-text assessment by the same reviewer. Study selection and eligibility decisions were verified by a second reviewer (S.B.), with any uncertainties resolved through discussion and consensus.
Data extraction was performed by one reviewer (M.S.) using a standardised data extraction form developed specifically for this review. The following data were extracted from each included study: study design, experimental model or clinical population, sample size, biomaterial or scaffold composition, intervention characteristics, outcome measures, duration of follow-up, and principal findings. The extracted data were subsequently verified by a second reviewer (S.B.) to ensure accuracy and completeness. Where multiple publications reported the same study population, the most recent publication was used for data extraction to minimise duplication of data.
Quality appraisal
The methodological quality of the included studies was assessed using appraisal tools appropriate to the study design. The SYRCLE Risk of Bias tool was used to evaluate in vivo animal studies, while the Joanna Briggs Institute (JBI) Critical Appraisal Tools were used to assess human clinical studies [26, 27].
Methodological quality assessment was undertaken by one reviewer (M.S.) using the predefined criteria for each appraisal tool. The completed assessments were subsequently reviewed by a second reviewer (S.B.), with any uncertainties resolved through discussion and consensus.
No studies were excluded on the basis of methodological quality or risk of bias. Instead, the findings of the quality appraisal informed the interpretation of the evidence and the overall conclusions of the review.
Certainty of evidence
Given the substantial clinical and methodological heterogeneity across the included studies, together with the absence of a quantitative synthesis, a formal GRADE assessment was not undertaken. Instead, the overall certainty of the evidence was considered narratively, taking into account study limitations, risk of bias, indirectness of the evidence, inconsistency across studies, and imprecision, consistent with published guidance for assessing certainty of evidence in systematic reviews without a single pooled estimate of effect [28].
Data synthesis
A quantitative meta-analysis was not undertaken because of substantial clinical and methodological heterogeneity across the included studies. Heterogeneity was evident in study design, experimental models, biomaterial composition, intervention protocols, outcome measures, and follow-up periods, precluding meaningful quantitative pooling of the data.
Instead, the findings were synthesised narratively using a structured approach. Studies were grouped according to biomaterial category (scaffold-based regenerative biomaterials and calcium-silicate biomaterials), study design and reported outcomes to facilitate comparison of the available evidence. The narrative synthesis was undertaken to identify patterns in biological response, regenerative potential and clinical outcomes while considering methodological quality, risk of bias, and the overall certainty of the evidence during interpretation of the findings.
Ethics approval and consent to participate
Ethical approval was not required as this study involved analysis of previously published data.
Results
The database search identified 1240 records. Following removal of 621 duplicate records, 619 studies underwent title and abstract screening. Of these, 30 articles were assessed for full-text eligibility, of which 11 met the predefined inclusion criteria and were included in the qualitative synthesis.
The included studies comprised five randomised clinical trials, one prospective cohort study, and five in vivo animal investigations. The study selection process is illustrated in Fig. 1, and the characteristics of the included studies are summarised in Table 1.
Flow diagram illustrating the identification, screening, eligibility assessment and inclusion of studies in the qualitative synthesis according to the PRISMA 2020 reporting guidelines.
The included evidence comprised five in vivo animal investigations evaluating scaffold-based regenerative biomaterials and six human clinical studies evaluating calcium-silicate biomaterials. Scaffold-based regenerative biomaterials were investigated exclusively in experimental animal models, whereas calcium-silicate biomaterials were assessed predominantly in permanent human teeth (Table 1).
Findings from scaffold-based regenerative biomaterials
Scaffold-based regenerative biomaterials were evaluated exclusively in in vivo animal models, including rat and rabbit models (Table 1). Sample sizes were generally small or not consistently reported, and follow-up periods were limited to short-term experimental observation.
Reported outcomes included increased angiogenesis, upregulation of odontogenic markers, and the formation of organised pulp-like tissue structures [20,21,22,23,24] In several studies, vascularised tissue resembling native pulp was observed alongside deposition of dentine-like structures [20,21,22,23,24] Scaffold interventions varied considerably in composition, architecture, and delivery systems, including hydrogel-based constructs, nanocomposite scaffolds, injectable bioceramic hydrogels, and three-dimensional printed scaffold systems (Table 1) [20,21,22,23,24].
Findings from calcium-silicate biomaterials
Clinical studies evaluating calcium-silicate biomaterials comprised five randomised clinical trials and one prospective cohort study involving permanent human teeth, with moderate sample sizes and follow-up periods typically ranging from 12 to 24 months (Table 1).
Clinical studies consistently reported high rates of pulpal vitality preservation and successful formation of reparative dentine bridges following VPT using calcium-silicate biomaterials, including mineral trioxide aggregate (MTA) and Biodentine [29,30,31,32,33,34]. Comparable clinical outcomes were also reported in studies evaluating pulpotomy using calcium-silicate biomaterials against root canal treatment [30,31,32]. Although overall success rates were high, some variability was observed between studies with respect to treatment protocols, follow-up duration, and reported clinical outcomes [29,30,31,32,33,34].
Comparative synthesis
No included studies directly compared scaffold-based regenerative biomaterials with calcium-silicate biomaterials within the same experimental or clinical study. Comparisons between regenerative scaffold approaches and calcium-silicate biomaterials were therefore indirect [20,21,22,23,24,29,30,31,32,33,34]. Effect sizes were not consistently reported across the included studies, precluding quantitative comparison and supporting the decision to undertake a narrative synthesis.
Risk of bias and methodological quality
Assessment of methodological quality demonstrated variability across both experimental and clinical studies.
Animal studies evaluated using the SYRCLE Risk of Bias tool demonstrated an overall moderate risk of bias, primarily due to limited reporting of randomisation procedures, allocation concealment, and blinding of outcome assessment.
Clinical studies assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Tools generally exhibited moderate to high methodological quality. Identified limitations included moderate sample sizes, variability in follow-up duration (typically 12–24 months), lack of blinding in some studies, operator-dependent variability, and potential selection bias associated with the prospective cohort study design.
Discussion
The present systematic review highlights a divergence between biological innovation and clinical translation in VPT. While scaffold-based regenerative biomaterials consistently demonstrated biological processes associated with dentine–pulp regeneration under experimental conditions, the current clinical evidence continues to support calcium-silicate biomaterials as the most predictable and reliable treatment option. Rather than representing conflicting findings, these observations reflect two distinct stages of translational development: scaffold-based regenerative biomaterials illustrate what may be biologically achievable, whereas calcium-silicate biomaterials represent what is currently reproducible in clinical practice. Consequently, the principal challenge facing regenerative endodontics is no longer demonstrating biological feasibility but translating these biological advances into predictable and clinically applicable therapies.
Both scaffold-based regenerative biomaterials and calcium-silicate biomaterials seek to achieve the same fundamental clinical objective: preservation of the vitality and function of the dentine–pulp complex. Consequently, considering these biomaterial strategies within the same systematic review provides an opportunity to evaluate the current evidence supporting each approach while recognising their differing stages of translational development. Importantly, the available literature does not permit direct comparison of their relative clinical performance, as scaffold-based regenerative biomaterials have been investigated almost exclusively in preclinical models, whereas calcium-silicate biomaterials have been evaluated predominantly in human clinical studies. Accordingly, comparisons within the present review should be interpreted as contextual evaluations of two biologically relevant treatment strategies rather than direct assessments of comparative clinical effectiveness.
The biological performance demonstrated by scaffold-based regenerative biomaterials across the included preclinical studies warrants careful consideration. Unlike calcium-silicate biomaterials, which primarily support reparative healing by providing a biologically favourable environment, scaffold-based regenerative biomaterials are specifically engineered to influence the regenerative microenvironment itself [12,13,14,15,16,17]. Across the included animal studies, scaffold systems consistently promoted angiogenesis, enhanced expression of odontogenic markers, and supported the formation of organised pulp-like tissue [20,21,22,23,24]. These findings suggest that scaffold-based regenerative biomaterials have the capacity to recreate important structural and biological features of the native dentine–pulp complex under controlled experimental conditions. Collectively, the available preclinical evidence illustrates the considerable advances achieved in biomaterials science and tissue engineering, while also highlighting the potential of scaffold-based regenerative strategies to extend beyond conventional reparative approaches.
Despite these encouraging biological findings, successful translation into reproducible therapeutic outcomes remains a considerable challenge. Regeneration of the dentine–pulp complex requires far more than the initiation of isolated biological processes; it depends upon the coordinated integration of angiogenesis, cellular differentiation, immune modulation, extracellular matrix remodelling, and functional tissue organisation within a highly constrained biological environment [1, 11,12,13, 16]. While these processes can be carefully controlled under experimental conditions, they are influenced in clinical practice by numerous variables, including microbial contamination, host immune responses, patient-specific biological variation, and procedural factors. Notably, most preclinical studies included in this review were conducted under controlled experimental conditions without microbial challenge, limiting their ability to replicate the complex biological environment encountered in clinical VPT [20,21,22,23,24]. Consequently, biological success achieved under experimental conditions should not be assumed to translate directly into consistent clinical outcomes.
One possible explanation for the translational paradox identified in the present review is the existence of a biological ceiling within contemporary VPT. This concept should not be interpreted as a fixed biological limit, but rather as an interpretative framework that emerges from the current evidence. Calcium-silicate biomaterials consistently achieve highly reproducible reparative outcomes that preserve pulpal vitality and support long-term clinical success [9, 10, 35,36,37]. However, despite the increasingly sophisticated biological responses demonstrated by scaffold-based regenerative biomaterials under experimental conditions, convincing evidence that these approaches can reproducibly exceed the clinical outcomes already achieved with calcium-silicate biomaterials remains unavailable [20,21,22,23,24]. Within this context, the biological ceiling may represent the point at which increasing biological sophistication no longer translates proportionately into clinically measurable benefit, at least with the technologies, outcome measures, and evidence currently available. This hypothesis does not imply that biological innovation has reached its limit; rather, it suggests that clinical translation may currently represent the principal barrier to further therapeutic advancement.
The hypothesis of a biological ceiling is biologically plausible when the intrinsic characteristics of the dentine–pulp complex are considered [1, 11, 12]. Unlike many other tissues, the dental pulp exists within a rigid, low-compliance environment in which vascular perfusion, immune regulation, neural function, and dentinogenesis must remain precisely coordinated to maintain tissue homeostasis [13, 16]. Successful regeneration therefore requires considerably more than the initiation of isolated biological processes; it depends upon the spatial and temporal integration of multiple cellular and molecular events within a confined anatomical space. Although scaffold-based regenerative biomaterials have demonstrated the capacity to promote angiogenesis, cellular differentiation, and organised tissue formation under experimental conditions, reproducing the structural organisation and functional integration of native pulp tissue within the clinical environment remains substantially more complex [20,21,22,23,24]. Consequently, increasing biological sophistication may not be sufficient to generate proportionately greater clinical benefit unless these regenerative processes can be translated into consistent, durable, and functionally integrated healing.
The interpretation of these findings must also be considered in the context of the available evidence. The inclusion of both animal and human studies was necessary to capture the continuum of evidence across the translational pathway, from mechanistic investigation to established clinical application. Animal models provide invaluable insight into biological mechanisms that cannot be investigated directly in human clinical studies, particularly with respect to angiogenesis, tissue organisation, and cellular differentiation [1, 11,12,13, 16]. However, they cannot fully replicate the biological complexity of human disease, including microbial challenge, age-related variation, host immune responses, and the procedural variables encountered in routine clinical practice. Consequently, while preclinical investigations remain essential for understanding regenerative mechanisms, their findings should be interpreted as informing biological plausibility rather than predicting clinical effectiveness.
The consistently favourable clinical performance of calcium-silicate biomaterials is unlikely to be explained by a single biological mechanism. Rather, their success appears to reflect the integration of several complementary properties, including excellent sealing ability, bioactivity, biocompatibility, and favourable antimicrobial characteristics [9, 10]. Together, these properties create a stable biological environment that supports predictable reparative healing, an outcome consistently supported by the available clinical evidence [35,36,37]. Importantly, successful VPT depends not only upon stimulating tissue repair, but also upon effective control of microbial contamination. In this respect, calcium-silicate biomaterials combine biological activity with clinical practicality, a combination that continues to be consistently supported by the available clinical evidence, as consistently demonstrated in recent systematic reviews and meta-analyses [35,36,37].
This interpretation is consistent with recent systematic reviews and meta-analyses, which have uniformly demonstrated favourable clinical outcomes for calcium-silicate biomaterials across a range of VPT procedures and reinforced their position as the current clinical benchmark. These reviews have consistently demonstrated favourable clinical outcomes across different treatment approaches and biomaterial comparisons while highlighting the continued importance of biologically based, minimally invasive management strategies [35,36,37]. Importantly, whereas these reviews primarily evaluate the clinical performance of established biomaterials, the present review additionally considers scaffold-based regenerative biomaterials within a translational framework, thereby extending current understanding beyond comparative clinical outcomes alone [35,36,37].
The findings of the present review suggest that the principal barriers to clinical translation extend beyond demonstration of biological feasibility. Although scaffold-based regenerative biomaterials consistently promoted regenerative processes under experimental conditions, the available evidence remains largely restricted to short-term preclinical investigations conducted under controlled laboratory conditions [20,21,22,23,24]. Consequently, important questions relating to long-term performance, reproducibility, and clinical implementation remain unanswered. In contrast, calcium-silicate biomaterials are supported by a substantial body of human clinical evidence demonstrating predictable outcomes under routine clinical conditions [35,36,37]. This contrast illustrates that successful translation requires not only biological innovation, but also robust clinical evidence capable of demonstrating reproducible patient benefit.
The methodological limitations of the available evidence should be considered when interpreting the findings of the present review. Nevertheless, these limitations largely reflect the current stage of regenerative endodontic research rather than shortcomings unique to the present analysis. By synthesising preclinical and clinical evidence within a single translational framework, this review provides a contemporary perspective on how biological innovation is progressing towards clinical application. Rather than attempting to establish comparative superiority between scaffold-based regenerative biomaterials and calcium-silicate biomaterials, the review identifies where the current evidence is strongest, where important uncertainties remain, and where future translational efforts should be directed. In doing so, it provides a framework for interpreting emerging regenerative technologies within the broader context of contemporary VPT.
Beyond the individual findings of the included studies, the present review offers an opportunity to reframe how regenerative endodontics is interpreted. Rather than viewing scaffold-based regenerative biomaterials and calcium-silicate biomaterials as competing technologies, the available evidence suggests that they currently represent different stages along the same translational pathway. Consequently, the future of regenerative endodontics should not be viewed simply as the pursuit of increasingly sophisticated biomaterials, but as the pursuit of clinically meaningful regeneration supported by robust translational evidence. This distinction is important because biological innovation and clinical innovation are not synonymous. Progress within the field will ultimately be determined not only by advances in biomaterial engineering, but also by the ability to demonstrate reproducible improvements in clinically relevant outcomes under routine clinical conditions.
The findings of the present review also provide a clear direction for future research. The immediate priority is no longer to demonstrate that scaffold-based regenerative biomaterials can stimulate biological regeneration under experimental conditions, but to establish whether these biological advantages translate into reproducible improvements in clinically relevant outcomes. Achieving this objective will require well-designed human clinical studies directly comparing scaffold-based regenerative biomaterials with calcium-silicate biomaterials using standardised outcome measures and sufficiently long follow-up periods. Future investigations should also incorporate clinically relevant models that better reflect the biological complexity of VPT, including microbial challenge, patient-related variability, and functional assessment of regenerated tissue. Addressing these priorities will strengthen the translational evidence base and help determine whether scaffold-based regenerative biomaterials can deliver clinically meaningful advantages beyond those currently achieved with calcium-silicate biomaterials.
Regenerative endodontics stands at an important stage in its evolution. The evidence synthesised in the present review suggests that the future of the field will depend not only upon continued biological innovation, but also upon understanding how that innovation can be translated into reproducible and clinically meaningful benefit. Calcium-silicate biomaterials remain the current benchmark for predictable VPT, while scaffold-based regenerative biomaterials continue to expand the biological possibilities of what may ultimately become achievable [35,36,37]. Whether these two paths will ultimately converge, or whether future advances will redefine the boundaries of pulp regeneration, remains one of the most compelling questions facing contemporary endodontics. The answer is unlikely to be determined by biological sophistication alone, but by our ability to understand when biological innovation truly becomes clinical innovation.
Conclusion
Current evidence supports calcium-silicate biomaterials as the clinical benchmark for VPT, while scaffold-based regenerative biomaterials demonstrate considerable biological promise that has yet to be translated into predictable clinical benefit. Rather than diminishing the significance of regenerative research, this distinction highlights the principal challenge facing contemporary regenerative endodontics: transforming biological innovation into reproducible improvements in patient care. Ultimately, the future of the field will be determined not only by what can be achieved under experimental conditions, but by what can be delivered consistently and meaningfully in clinical practice. Whether future regenerative strategies will ultimately redefine the boundaries of VPT remains an open question, one that will be answered not by biological innovation alone, but by the strength of the clinical evidence that follows.
Data availability
All data analysed during this study are included in the published article. No new datasets were generated.
References
Galler KM, Weber M, Korkmaz Y, Widbiller M, Feuerer M. Inflammatory response mechanisms of the dentine–pulp complex and the periapical tissues. Int J Mol Sci. 2021;22:1480.
Ricucci D, Loghin S, Siqueira JF. Correlation between clinical and histologic pulp diagnoses. J Endod. 2014;40:1932–9.
Simon S, Perard M, Zanini M, Smith AJ, Charpentier E, Djole SX, et al. Should pulp chamber pulpotomy be seen as a permanent treatment? Some preliminary thoughts. Int Endod J. 2013;46:79–87.
Taha NA, Khazali MA. Partial pulpotomy in mature permanent teeth with clinical signs indicative of irreversible pulpitis: a randomised clinical trial. J Endod. 2017;43:1417–21.
Aguilar P, Linsuwanont P. Vital pulp therapy in vital permanent teeth with cariously exposed pulp: a systematic review. J Endod. 2011;37:581–7.
Hilton TJ, Ferracane JL. Pulp capping with calcium hydroxide and mineral trioxide aggregate: comparison of success rates. Oper Dent. 2010;35:431–6.
Bjørndal L, Simon S, Tomson PL, Duncan HF. Management of deep caries and the exposed pulp. Int Endod J. 2019;52:949–73.
Duncan HF, Galler KM, Tomson PL, Simon S, El-Karim IA, Kundzina R, et al. European Society of Endodontology position statement: management of deep caries and the exposed pulp. Int Endod J. 2019;52:923–34.
Parirokh M, Torabinejad M. Mineral trioxide aggregate: a comprehensive literature review—Part I: chemical, physical and antibacterial properties. J Endod. 2010;36:16–27.
Camilleri J. Biodentine: a dentine substitute and a bioactive material. J Dent. 2013;41:613–20.
Galler KM, D’Souza RN, Federlin M, Cavender AC, Hartgerink JD, Hecker S, et al. Dentin conditioning codetermines cell fate in regenerative endodontics. J Endod. 2011;37:1536–41.
Nakashima M, Iohara K. Regeneration of dental pulp by stem cells. Adv Dent Res. 2011;23:313–9.
Rosa V, Zhang Z, Grande RH, Nör JE. Dental pulp tissue engineering in full-length human root canals. J Dent Res. 2013;92:970–5.
Murray PE, Garcia-Godoy F, Hargreaves KM. Regenerative endodontics: a review of current status and a call for action. J Endod. 2007;33:377–90.
Hargreaves KM, Diogenes A, Teixeira FB. Treatment options: biological basis of regenerative endodontic procedures. J Endod. 2013;39:S30–S43.
Schmalz G, Widbiller M, Galler KM. Signaling molecules and pulp regeneration. J Endod. 2017;43:S7–S11.
Widbiller M, Schmalz G. Endodontic regeneration: hard tissue formation and tissue engineering approaches. J Endod. 2015;41:S27–S36.
Huang GT. Pulp and dentin tissue engineering and regeneration: current progress. J Dent Res. 2009;88:639–47.
Diogenes A, Ruparel NB, Shiloah Y, Hargreaves KM. Regenerative endodontics: a way forward. J Am Dent Assoc. 2016;147:372–80.
Cunha RS, Sinjari B, De-Deus G, et al. Regenerative potential of 3D-printed GelMA microgels combined with dentine matrix proteins in vital pulp therapy: an experimental study. J Endod. 2023;49:1012–20.
Han L, Zhang L, Chen X, Li Y, Wang Y, Liu H, et al. Evaluation of GelMA/β-TCP nanocomposite scaffolds for pulp tissue regeneration in a rat molar model. Acta Biomater. 2024;170:245–56.
Tao X, Chen Y, Zhang J, Li M, Wang X, Liu Z, et al. Injectable bioceramic hydrogel scaffolds promote neurovascular regeneration in vital pulp therapy. Bioact Mater. 2025;32:112–23.
Yi J, Wang Z, Li Q, Chen Y, Zhang X, Liu Y, et al. Hierarchical hydrogel scaffolds for dentine–pulp complex regeneration in a rat model. Biomaterials. 2024;301:122257.
Zhang Y, Liu H, Wang X, Chen Z, Li J, Zhao Y, et al. Nanocomposite scaffolds for regeneration of the dentine–pulp complex: an in vivo rabbit study. Dent Mater. 2024;40:365–74.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Joanna Briggs Institute. JBI Manual for Evidence Synthesis. Adelaide: Joanna Briggs Institute; 2020.
Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.
Murad MH, Mustafa RA, Schünemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22:85–87.
Aguilar P, Linsuwanont P, Taha NA, et al. Randomised clinical trial comparing mineral trioxide aggregate and Biodentine in vital pulp therapy of permanent teeth. Int Endod J. 2021;54:1125–34.
Silva EJNL, Rover G, Belladonna FG, et al. Clinical evaluation of Biodentine pulpotomy compared with root canal treatment in mature permanent teeth: a randomised clinical trial. J Endod. 2025;51:215–23.
Taha NA, Abdelkhader SZ, Khazali MA, et al. Outcomes of full pulpotomy using bioceramic putty versus root canal treatment in mature permanent teeth: a randomised clinical trial with 24-month follow-up. Int Endod J. 2023;56:684–93.
Zhu Q, Li R, Peng B, et al. Clinical outcomes of vital pulp therapy using iRoot BP Plus compared with root canal treatment: a prospective cohort study. Clin Oral Investig. 2024;28:1221–30.
Baranwal AK, Meena N, Yadav S, et al. Randomised clinical trial comparing Biodentine and mineral trioxide aggregate for pulpotomy in permanent teeth. J Endod. 2025;51:410–8.
Gilhotra JS, Gill GS, Kaur A, et al. Comparative clinical evaluation of Biodentine, MTA, Bio-C Repair and EndoSequence BC-RRM in vital pulp therapy: a randomised controlled trial. Clin Oral Investig. 2024;28:4875–84.
Asgary S, Shamszadeh S, Shirvani A, et al. Management strategies for pulpitis in vital permanent teeth in children and adolescents: a systematic review and meta-analysis of randomized clinical trials. Eur Arch Paediatr Dent. 2025;26:451–63.
Komora P, Vámos O, Gede N, et al. Comparison of bioactive material failure rates in vital pulp treatment of permanent matured teeth: a systematic review and network meta-analysis. Sci Rep. 2024;14:18421.
Lamb AR, Ghivari S, Meshram R, et al. Comparative evaluation of calcium-enriched mixture and mineral trioxide aggregate in vital pulp therapy of molars: a systematic review. J Conserv Dent Endod. 2026;29:127–34.
Funding
The research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Author information
Authors and Affiliations
Simplyendo®, Formby, UK
Marisa Menezes Santana & Simon John Barnwell
University of Chester, Chester, UK
Marisa Menezes Santana & Simon John Barnwell
Authors
- Marisa Menezes Santana
- Simon John Barnwell
Contributions
Marisa Menezes Santana: Conceptualisation, methodology, literature search, data curation, formal analysis, writing—original draft. Simon John Barnwell: Supervision, methodology validation, writing—review & editing.
Corresponding author
Correspondence to Marisa Menezes Santana.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Menezes Santana, M., Barnwell, S.J. Scaffold-based and calcium-silicate biomaterials in vital pulp therapy: a systematic review of current evidence and translational perspectives. BDJ Open 12, 103 (2026). https://doi.org/10.1038/s41405-026-00480-7
Received: 26 April 2026
Revised: 23 July 2026
Accepted: 24 July 2026
Published: 31 October 2026
Version of record: 31 October 2026
DOI: https://doi.org/10.1038/s41405-026-00480-7
来源:Nature 健康护理主题 · nature.com